Veea Inc is a company providing an edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades... Show more
Veea Inc. is an AI-driven edge infrastructure company founded in 2014 and headquartered in New York City. The company develops the VeeaHub line of smart connectivity and computing hubs and the VeeaONE platform, a hyperconverged edge-to-cloud software stack that merges compute, storage, networking, and cybersecurity into a unified solution. Its offerings include the SecureConnect and AirLynx service platforms, a VeeaONE IoT platform, and the Niagara building and energy management system.
Veea sells to enterprises, service providers, and public-sector organizations seeking to run AI applications close to where data is generated, with an emphasis on latency, data privacy, and resilience. The business is small in scale, with roughly 45 employees and reported 2025 revenue of about $222,000. Investors follow the stock for its exposure to the Edge AI theme and, more recently, for its proposed pivot into digital health through the NovaGen combination.
Over the last 30 days, VEEA delivered an exceptional move. The split-adjusted closing price stood near $1.56 on September 11, 2026, and reached $4.61 by October 12, 2026, a gain of roughly +195%. The move was not linear: the stock spiked to $5.71 on September 15 and again to $5.72 on October 5 before pulling back as momentum cooled.
Viewed over the trailing quarter, the picture is more complex. From approximately $4.75 in early July 2026, the shares ended around $4.61, a modest net decline of about 3%. That headline figure, however, conceals a deep drawdown to a post-reverse-split low near $1.56 in mid-September followed by the merger-driven rebound — among the most volatile stretches in the company's recent trading history. A 1-for-20 reverse stock split that took effect August 31, 2026 is reflected in all quoted prices.
The dominant catalyst was the September 14 announcement that Veea and NovaGen Group had signed a term sheet to combine. The proposed transaction would create NovaGen Health Networks, an edge AI-powered global health platform linking Veea's edge infrastructure with NovaGen's regenerative medicine and clinical services. GeoNova Capital signed a parallel term sheet to invest $10 million as a cornerstone investor, and the companies indicated an approximately $750 million valuation for the combined entity. VEEA surged roughly 149% in a single session on September 15, with volume reaching over 100 million shares versus a prior three-month average near 150,000.
A second leg higher came October 1, when Veea announced an agreement with TROLLEE Holdings for the phased deployment of VeeaONE across 1,000 unattended stores, beginning with up to 50 locations. Shares jumped nearly 48% intraday on unusually heavy volume. In early October, Veea also confirmed it had regained full compliance with Nasdaq continued-listing requirements, removing a structural concern that had weighed on sentiment.
The broader three-month trend was defined by a struggle for listing compliance and liquidity, followed by a strategic reinvention. Veea entered the quarter trading below Nasdaq's minimum bid price requirements, prompting a 1-for-20 reverse stock split effective August 31 to lift the share price. Even after the split, the stock slid toward $1.56 by mid-September as investors weighed the company's thin revenue base and cash needs.
The narrative shifted with the NovaGen term sheet, which repositioned Veea from a niche edge-computing vendor toward a healthcare-oriented platform. Supporting the quarter's momentum were a technology services distribution agreement with Telarus and a smart-community deployment with the La Estadia community, alongside the TROLLEE expansion. Together, these developments reframed the investment case, though the company's micro-cap structure and low float continued to amplify every move.
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots drawn from a platform offering hundreds of bots that trade thousands of tickers. Only the top-performing and most relevant bots are featured in this section, giving traders a focused view of strategies currently attracting attention. The bots vary widely in approach, timeframe, and performance metrics, so users can compare different systems before exploring further. For those tracking volatile names like VEEA, the page offers a useful lens on how automated strategies are positioning across the market.
The near-term outlook hinges on execution. Investors will be watching whether Veea and NovaGen finalize a definitive business combination agreement and whether the planned NovaGen Health Networks rollout begins at clinics and partner hospitals in the fourth quarter of 2026. Progress on the TROLLEE deployment and any additional funding beyond GeoNova's $10 million commitment are also key.
On the fundamentals, revenue generation, operating cash burn, and the company's accumulated deficit remain central risks, as does its ability to maintain Nasdaq compliance after the reverse split. Given the limited float and low liquidity, continued volatility is likely as each announcement is priced. These factors are worth monitoring rather than treating as a basis for any specific investment decision.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for VEEA turned positive on October 01, 2026. Looking at past instances where VEEA's MACD turned positive, the stock continued to rise in 11 of 11 cases over the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on VEEA as a result. In 19 of 24 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VEEA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.619) is normal, around the industry mean (2.669). P/E Ratio (-0.838) is within average values for comparable stocks, (16.523). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.112) among similar stocks. P/S Ratio (30.769) is also within normal values, averaging (139.965).
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. VEEA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VEEA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InformationTechnologyServices